Free Trial

Amgen (AMGN) SEC Filings & 10K Form

Amgen logo
$298.25 +1.40 (+0.47%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$298.25 0.00 (0.00%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amgen SEC Filings

DateFilerForm TypeView
06/06/2025
6:49 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
11:24 AM
Amgen (Subject)
Khosla Rachna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2025
8:00 PM
Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
8:01 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
8:02 PM
Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
8:04 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
8:05 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
8:06 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
8:07 PM
Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
7:56 PM
Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
7:57 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
7:58 PM
Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
7:59 PM
Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
8:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:53 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:55 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:56 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:57 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:58 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:59 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
8:01 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:49 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:50 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:52 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:13 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:39 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:59 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:11 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:13 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:14 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:15 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:15 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:16 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:05 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:07 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:08 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:10 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:27 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:28 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:29 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:30 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Revealed: NEW A.I. revolution (nobody is talking about) (Ad)

Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to open up a $24 trillion investment opportunity. Making it even bigger than cars, computers, and cell phones... COMBINED. A 33+ year market expert has just revealed how early investors could position themselves today for extraordinary gains from this new wave of A.I. in the coming months and years...

→ Watch his brand new presentation here ←
05/02/2025
8:31 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:32 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:25 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:26 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
1:37 PM
Amgen (Subject)
Busch Matthew C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2025
4:25 PM
Amgen (Filer)
Form DEFA14A
04/16/2025
11:44 AM
Amgen (Subject)
Chevedden John (Filed by)
Form PX14A6G
04/09/2025
7:35 AM
Amgen (Filer)
Form DEFA14A
04/09/2025
7:30 AM
Amgen (Filer)
Form DEF 14A
04/02/2025
8:00 AM
Amgen (Filer)
Form ARS
03/19/2025
7:17 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:18 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:19 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:20 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:21 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:22 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:22 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:14 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:15 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:16 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:58 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:05 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:06 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:06 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:07 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:08 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:09 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:55 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:56 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:57 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
7:06 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
7:07 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:27 PM
Amgen (Subject)
REESE DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
7:59 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
1:25 PM
Amgen (Subject)
Santos Esteban (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
8:02 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:01 PM
Amgen (Subject)
Gordon Murdo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
8:52 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:54 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
11:53 AM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:05 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
5:17 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:48 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:37 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:38 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:41 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:45 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:46 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)

Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.

Now he's identified his next potential winner. Click here to find out more.
08/23/2024
3:20 PM
Amgen (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/13/2024
4:44 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:41 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:00 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMGN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners